FDA Releases Final Guidance on Chemical Drug Starting Materials

International Pharmaceutical Regulatory Monitor
A A
The FDA finalized a Q&A guidance clarifying the International Council for Harmonization’s November 2012 Q11 guidance on development and manufacture of drug substances — giving recommendations for information that should be provided in authorization applications for starting materials.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor